Early Recognition of Immune‐Related Hepatitis During Avelumab Maintenance Therapy for Urothelial Carcinoma
Hepatic irAEs during avelumab therapy are rare but potentially fatal. Early recognition and aggressive multidisciplinary management are essential to improve outcomes.
Authors
- Kazuna Matsuo (ORCID: https://orcid.org/0000-0001-8574-2932)
- Y. Matsukawa
- Tomoyasu Sano
- Shohei Ishida
- Shusuke Akamatsu (ORCID: https://orcid.org/0000-0002-1394-7506)
- Tomokazu Kimura (ORCID: https://orcid.org/0000-0003-1201-1260)
- Yuta Sano
- Satoshi Inoue
- Yuka Iwama
- Yushi Naito
Institutions
- Nagoya University Hospital (JP)
- Nagoya University (JP)
Publication Details
- Journal
- IJU Case Reports
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1002/iju5.70150
- Citations
- 1
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 24.20